In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy

Abstract Background and purpose The tumor microenvironment (TME) is widely acknowledged as a pivotal regulator of cancer progression. However, the dualistic role of tertiary lymphoid structures (TLSs), which serve as critical immune hubs within the TME, remains incompletely characterized, particular...

Full description

Saved in:
Bibliographic Details
Main Authors: Maedeh Radandish, Niloofar Mashhadi, Amir Hossein Aghayan, Motahareh Taghizadeh, Sara Salehianfard, Sheida Yahyazadeh, Omid Vakili, Somayeh Igder
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Experimental Hematology & Oncology
Subjects:
Online Access:https://doi.org/10.1186/s40164-025-00695-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849766646439215104
author Maedeh Radandish
Niloofar Mashhadi
Amir Hossein Aghayan
Motahareh Taghizadeh
Sara Salehianfard
Sheida Yahyazadeh
Omid Vakili
Somayeh Igder
author_facet Maedeh Radandish
Niloofar Mashhadi
Amir Hossein Aghayan
Motahareh Taghizadeh
Sara Salehianfard
Sheida Yahyazadeh
Omid Vakili
Somayeh Igder
author_sort Maedeh Radandish
collection DOAJ
description Abstract Background and purpose The tumor microenvironment (TME) is widely acknowledged as a pivotal regulator of cancer progression. However, the dualistic role of tertiary lymphoid structures (TLSs), which serve as critical immune hubs within the TME, remains incompletely characterized, particularly with respect to their context-dependent capacity to either inhibit or facilitate tumor development. This review aims to synthesize current understanding of the complex interactions between stromal cells and TLSs, addressing existing gaps in mechanistic insight and exploring therapeutic avenues to exploit TLS plasticity. Key reviewed topics The current study critically reviews the mechanisms by which stromal components, including cancer-associated fibroblasts and endothelial cells, contribute to TLS neogenesis through chemokine-mediated recruitment of lymphocytes. Furthermore, it highlights the dual functional roles of TLSs as sites of both anti-tumor immune activation and immunosuppression, notably via the enrichment of regulatory T cells. The clinical implications of mature TLS presence, particularly their association with improved patient prognosis and enhanced therapeutic responsiveness, are also analyzed. Main conclusions TLSs demonstrate a bifunctional nature, wherein their spatial organization and dynamic interactions with stromal elements dictate the balance between immune activation and tolerance within the TME. While mature TLSs are generally correlated with favorable clinical outcomes, their potential to foster immunosuppressive microenvironments necessitates the development of precision-targeted interventions. The interplay between stromal cells and TLSs represents a promising therapeutic axis for modulating the tumor immune milieu. Future perspectives Future research should prioritize strategies aimed at promoting TLS maturation, disrupting immunosuppressive niches, and integrating TLS-modulating agents with existing immunotherapeutic regimens to enhance clinical efficacy. Additionally, the identification of robust biomarkers reflective of TLS functional states and the rigorous validation of stromal-targeted therapies within combinatorial treatment frameworks are imperative for advancing translational applications. Graphical abstract
format Article
id doaj-art-1a42818143764021841a4e78978bfb08
institution DOAJ
issn 2162-3619
language English
publishDate 2025-08-01
publisher BMC
record_format Article
series Experimental Hematology & Oncology
spelling doaj-art-1a42818143764021841a4e78978bfb082025-08-20T03:04:30ZengBMCExperimental Hematology & Oncology2162-36192025-08-0114113410.1186/s40164-025-00695-8In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapyMaedeh Radandish0Niloofar Mashhadi1Amir Hossein Aghayan2Motahareh Taghizadeh3Sara Salehianfard4Sheida Yahyazadeh5Omid Vakili6Somayeh Igder7Department of Immunology, School of Medicine, Isfahan University of Medical SciencesDepartment of Immunology, School of Medicine, Shiraz University of Medical SciencesDepartment of Medical Laboratory Sciences, School of Paramedical Sciences, Zanjan University of Medical SciencesDepartment of Clinical Biochemistry, School of Medicine, Shiraz University of Medical SciencesDepartment of Clinical Biochemistry, School of Medicine, Shahid Sadoughi University of Medical SciencesDepartment of Immunology, School of Medicine, Shiraz University of Medical SciencesDepartment of Clinical Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical SciencesDepartment of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical SciencesAbstract Background and purpose The tumor microenvironment (TME) is widely acknowledged as a pivotal regulator of cancer progression. However, the dualistic role of tertiary lymphoid structures (TLSs), which serve as critical immune hubs within the TME, remains incompletely characterized, particularly with respect to their context-dependent capacity to either inhibit or facilitate tumor development. This review aims to synthesize current understanding of the complex interactions between stromal cells and TLSs, addressing existing gaps in mechanistic insight and exploring therapeutic avenues to exploit TLS plasticity. Key reviewed topics The current study critically reviews the mechanisms by which stromal components, including cancer-associated fibroblasts and endothelial cells, contribute to TLS neogenesis through chemokine-mediated recruitment of lymphocytes. Furthermore, it highlights the dual functional roles of TLSs as sites of both anti-tumor immune activation and immunosuppression, notably via the enrichment of regulatory T cells. The clinical implications of mature TLS presence, particularly their association with improved patient prognosis and enhanced therapeutic responsiveness, are also analyzed. Main conclusions TLSs demonstrate a bifunctional nature, wherein their spatial organization and dynamic interactions with stromal elements dictate the balance between immune activation and tolerance within the TME. While mature TLSs are generally correlated with favorable clinical outcomes, their potential to foster immunosuppressive microenvironments necessitates the development of precision-targeted interventions. The interplay between stromal cells and TLSs represents a promising therapeutic axis for modulating the tumor immune milieu. Future perspectives Future research should prioritize strategies aimed at promoting TLS maturation, disrupting immunosuppressive niches, and integrating TLS-modulating agents with existing immunotherapeutic regimens to enhance clinical efficacy. Additionally, the identification of robust biomarkers reflective of TLS functional states and the rigorous validation of stromal-targeted therapies within combinatorial treatment frameworks are imperative for advancing translational applications. Graphical abstracthttps://doi.org/10.1186/s40164-025-00695-8NeoplasmsCancer immunotherapyTumor microenvironmentStromal cell immunomodulationTertiary lymphoid structuresTumor infiltration
spellingShingle Maedeh Radandish
Niloofar Mashhadi
Amir Hossein Aghayan
Motahareh Taghizadeh
Sara Salehianfard
Sheida Yahyazadeh
Omid Vakili
Somayeh Igder
In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy
Experimental Hematology & Oncology
Neoplasms
Cancer immunotherapy
Tumor microenvironment
Stromal cell immunomodulation
Tertiary lymphoid structures
Tumor infiltration
title In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy
title_full In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy
title_fullStr In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy
title_full_unstemmed In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy
title_short In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy
title_sort in depth insight into tumor infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy
topic Neoplasms
Cancer immunotherapy
Tumor microenvironment
Stromal cell immunomodulation
Tertiary lymphoid structures
Tumor infiltration
url https://doi.org/10.1186/s40164-025-00695-8
work_keys_str_mv AT maedehradandish indepthinsightintotumorinfiltratingstromalcellslinkedtotertiarylymphoidstructuresandtheirprospectivefunctionincancerimmunotherapy
AT niloofarmashhadi indepthinsightintotumorinfiltratingstromalcellslinkedtotertiarylymphoidstructuresandtheirprospectivefunctionincancerimmunotherapy
AT amirhosseinaghayan indepthinsightintotumorinfiltratingstromalcellslinkedtotertiarylymphoidstructuresandtheirprospectivefunctionincancerimmunotherapy
AT motaharehtaghizadeh indepthinsightintotumorinfiltratingstromalcellslinkedtotertiarylymphoidstructuresandtheirprospectivefunctionincancerimmunotherapy
AT sarasalehianfard indepthinsightintotumorinfiltratingstromalcellslinkedtotertiarylymphoidstructuresandtheirprospectivefunctionincancerimmunotherapy
AT sheidayahyazadeh indepthinsightintotumorinfiltratingstromalcellslinkedtotertiarylymphoidstructuresandtheirprospectivefunctionincancerimmunotherapy
AT omidvakili indepthinsightintotumorinfiltratingstromalcellslinkedtotertiarylymphoidstructuresandtheirprospectivefunctionincancerimmunotherapy
AT somayehigder indepthinsightintotumorinfiltratingstromalcellslinkedtotertiarylymphoidstructuresandtheirprospectivefunctionincancerimmunotherapy